July 14, 1962

Drugs Evaluated by the Council on Drugs During 1961

JAMA. 1962;181(2):142-146. doi:10.1001/jama.1962.03050280072005j

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


ONE OF THE FUNCTIONS of the Council on Drugs is to examine and evaluate available evidence relating to the actions, uses, dosage, hazards, and other pertinent properties of drugs and to encourage rational therapy by timely, informative reports to the medical profession. The views of the Council with respect to these characteristics of each evaluated drug are incorporated in a monograph which is included in the Council's annual publication, New and Nonofficial Drugs.

To make it possible for the busy physician readily to ascertain the Council's opinion on new drugs,digests of monographs of recently evaluated drugs are published periodically in The Journalof the American Medical Association, and brief summaries of statements on the drugs evaluated during the year 1961 are compiled here. This summary of drugs evaluated by the Council is an annual feature of the Therapeutic Number of The Journal.

Amino-glutethimide (Elipten).—A moderately effective anticonvulsant; however, a high incidence

First Page Preview View Large
First page PDF preview
First page PDF preview